Iovance Biotherapeutics (IOVA) EPS (Weighted Average and Diluted) (2023 - 2025)
Historic EPS (Weighted Average and Diluted) for Iovance Biotherapeutics (IOVA) over the last 5 years, with Q2 2025 value amounting to -$0.33.
- Iovance Biotherapeutics' EPS (Weighted Average and Diluted) rose 294.12% to -$0.33 in Q2 2025 from the same period last year, while for Jun 2025 it was -$1.22, marking a year-over-year increase of 2694.61%. This contributed to the annual value of -$1283.9 for FY2024, which is 6783193.24% down from last year.
- As of Q2 2025, Iovance Biotherapeutics' EPS (Weighted Average and Diluted) stood at -$0.33, which was up 294.12% from -$0.36 recorded in Q1 2025.
- In the past 5 years, Iovance Biotherapeutics' EPS (Weighted Average and Diluted) registered a high of -$0.33 during Q2 2025, and its lowest value of -$275.47 during Q3 2024.
- Over the past 3 years, Iovance Biotherapeutics' median EPS (Weighted Average and Diluted) value was -$0.45 (recorded in 2023), while the average stood at -$54.99.
- Within the past 5 years, the most significant YoY rise in Iovance Biotherapeutics' EPS (Weighted Average and Diluted) was 2765.96% (2024), while the steepest drop was 6013474.32% (2024).
- Over the past 3 years, Iovance Biotherapeutics' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.45 in 2023, then plummeted by 60134.74% to -$271.06 in 2024, then skyrocketed by 99.88% to -$0.33 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.33 in Q2 2025, compared to -$0.36 in Q1 2025 and -$271.06 in Q4 2024.